Gynecologic Oncology Network
Greenville, North Carolina 27858
0 studies enrolling now · 14 studies all time
What they study most
Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Childhood Embryonal Rhabdomyosarcoma, Childhood Malignant Ovarian Germ Cell Tumor, Complete Hydatidiform Mole, Endometrial Cancer
Studies at this site
- Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer — Completed
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer — Status unconfirmed
- Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer — Completed
- VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Completed
- Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer — Completed
- Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia — Completed
- Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors — Completed
- Collecting Tumor Samples From Patients With Gynecological Tumors — Completed
- Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus — Completed
- Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
- Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed
- Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass — Status unconfirmed